Bg pattern

ALPHAGAN 2 mg/ml EYE DROPS SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ALPHAGAN 2 mg/ml EYE DROPS SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Alphagan 2 mg/ml

eye drops, solution.

brimonidine tartrate

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack and other information

  1. What is Alphagan and what is it used for
  2. What you need to know before you use Alphagan
  3. How to use Alphagan
  4. Possible side effects
  5. Storing Alphagan
  6. Contents of the pack and other information

1. What is Alphagan and what is it used for

Alphagan is used to lower high pressure in the eye. The active substance in Alphagan, brimonidine tartrate, belongs to a group of medicines called alpha-2 adrenergic agonists and works by reducing the amount of fluid produced in the eye.

It can be used on its own, when beta-blocker eye drops are not suitable, or with other eye drops, when Alphagan alone is not enough to lower the pressure in the eye in the treatment of open-angle glaucoma or ocular hypertension.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Alphagan

Do not use Alphagan

  • If you are allergic (hypersensitive) to brimonidine tartrate or any of the other ingredients of this medicine (listed in section 6)
  • If you are taking monoamine oxidase inhibitors (MAOIs) or certain other antidepressants. You should tell your doctor if you are taking any antidepressant medication.
  • If you are breast-feeding.
  • In children/babies (up to 2 years of age).

Warnings and precautions

Tell your doctor before using Alphagan:

  • If you have or have had depression, reduced mental ability, reduced blood flow to the brain, heart problems, poor circulation to your hands or feet, or a blood pressure disorder.
  • If you have or have had kidney or liver problems.

Children and adolescents

Alphagan is not recommended for use in children between 2 and 12 years old.

Alphagan should not be used in adolescents from 12 to 17 years old, as no clinical studies have been conducted in this age group.

Other medicines and Alphagan

Tell your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription.

Tell your doctor if you are using any of the following medicines:

  • Painkillers, sedatives, opioids, barbiturates, or if you are regularly drinking alcohol.
  • Anaesthetics.
  • Medicines for heart conditions or to lower blood pressure.
  • Medicines that can affect metabolism, such as chlorpromazine, methylphenidate, and reserpine.
  • Medicines that act on the same receptor as Alphagan, such as isoprenaline and prazosin.
  • MAOIs and other antidepressants.
  • Medicines for any condition, including those not related to your eye condition.
  • Or if the dose of any of your current medicines changes.

These may affect your treatment with Alphagan.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Do not use Alphagan if you are pregnant unless your doctor considers it necessary.

Alphagan should not be used during breast-feeding.

Driving and using machines

  • Alphagan may cause blurred or abnormal vision. This effect may be increased in the dark or with reduced lighting.
  • Alphagan may also cause drowsiness or fatigue in some patients.
  • If you experience any of these symptoms, do not drive or use machines until the symptoms have resolved.

Alphagan contains benzalkonium chloride

This medicine contains 0.25 mg of benzalkonium chloride in every 5 ml of solution, equivalent to 0.05 mg/ml.

Benzalkonium chloride may be absorbed by soft contact lenses and change their colour. Remove contact lenses before using this medicine and wait 15 minutes before putting them back.

Benzalkonium chloride may cause eye irritation, especially if you have dry eyes or other corneal diseases (the transparent layer on the front of the eye). Talk to your doctor if you feel any unusual sensation, itching, or pain in the eye after using this medicine.

3. How to use Alphagan

Use Alphagan exactly as your doctor has told you. Ask your doctor or pharmacist if you are not sure.

Adults

The recommended dose is one drop twice a day in the affected eye(s), approximately 12 hours apart. Do not change the dose or stop using Alphagan without talking to your doctor.

Children under 12 years

Alphagan should not be used in children under 2 years of age.

Alphagan is not recommended for use in children between 2 and 12 years old.

Instructions for use

Alphagan comes as eye drops. Always wash your hands before applying the eye drops. Your prescription will tell you how many drops to use for each dose. If you use Alphagan with another eye drop, wait 5-15 minutes before applying the second eye drop.

Apply your eye drops as follows:

Open eye, eye with dropper being applied, lower eyelid and profile of eye and nose

  1. Tilt your head back and look up at the ceiling.
  2. Gently pull down the lower eyelid to make a small pocket.
  3. Squeeze the bottle gently to release one drop into your eye.
  4. Keep the affected eye closed and press your finger against the corner of your closed eye (where the eye meets the nose) for 1 minute.

If the drop falls outside the eye, try again.

To avoid contamination, do not let the tip of the bottle touch the eye or any other surface.

Put the cap back on and close the bottle immediately after use.

If you use more Alphagan than you should

Adults

In adults who applied more drops than prescribed, the adverse effects reported were those already known with Alphagan.

Adults who accidentally ingested Alphagan experienced a decrease in blood pressure, which in some patients was followed by an increase in blood pressure.

Children

Serious adverse effects have been reported in children who accidentally ingested Alphagan. The signs included drowsiness, hypotonia, low body temperature, pallor, and breathing difficulties. If this happens, contact your doctor immediately.

Adults and children

If you have accidentally ingested Alphagan or used more Alphagan than you should, contact your doctor immediately.

If you forget to use Alphagan

If you forget to apply a dose, use it as soon as you remember. However, if it is almost time for your next dose, you should skip the missed dose and continue with your regular schedule. Do not use a double dose to make up for missed doses.

If you stop using Alphagan

To be effective, Alphagan must be used every day. Do not stop using Alphagan without talking to your doctor.

If you have any questions about using this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects may occur with Alphagan.

Affecting the eye

Very common (affects more than 1 in 10 people):

  • Eye irritation (redness of the eye, burning, stinging, feeling of something in the eye or itching) Follicles or white spots on the transparent layer covering the surface of the eye)
  • Blurred vision
  • An allergic reaction in the eyes

Common (affects up to 1 in 10 people):

  • Local irritation (inflammation and swelling of the eyelid, sticky eyes, swelling of the eyelid or the transparent layer covering the surface of the eye, pain and tearing)
  • Sensitivity to light
  • Erosion on the surface of the eye and discoloration
  • Dry eye
  • Whitening of the transparent layer covering the surface of the eye.
  • Abnormal vision
  • Inflammation of the transparent layer covering the surface of the eye.

Very rare (affects up to 1 in 10,000 people):

  • Inflammation in the eye
  • Reduced pupil size.

Frequency not known (frequency cannot be estimated from the available data):

  • Itching of the eyelids

Affecting the body:

Very common (affects more than 1 in 10 people):

  • Headache,
  • Dry mouth
  • Fatigue/drowsiness.

Common (affects up to 1 in 10 people):

  • Dizziness
  • Cold symptoms
  • Symptoms affecting the stomach and digestion
  • Altered taste
  • General weakness.

Uncommon (affects up to 1 in 100 people):

  • Depression
  • Palpitations or changes in heart rate
  • Dry nose
  • General allergic reactions.

Rare (affects up to 1 in 1,000 people):

  • Respiratory failure.

Very rare (affects up to 1 in 10,000 people):

  • Insomnia
  • Fainting
  • High blood pressure.
  • Low blood pressure.

Frequency not known (frequency cannot be estimated from the available data):

  • Skin reactions including redness, inflammation of the face, itching, rash, and dilation of blood vessels.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) at www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Alphagan

  • Keep this medicine out of the sight and reach of children.
  • Do not store above 25°C.
  • Do not use this medicine if you notice that the security seal of the bottle is broken before the first use.
  • Do not use Alphagan after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month stated.
  • Discard the bottle 28 days after opening, even if there is solution left.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What is in Alphagan

  • The active substance is brimonidine tartrate. One ml of solution contains 2.0 mg of brimonidine tartrate, equivalent to 1.3 mg of brimonidine.
  • The other ingredients are benzalkonium chloride as a preservative, poly(vinyl alcohol), sodium chloride, sodium citrate, citric acid monohydrate, purified water, and sodium hydroxide or hydrochloric acid for pH adjustment.

What Alphagan looks like and contents of the pack

Alphagan is a clear, greenish-yellow to light greenish-yellow eye drop solution in a plastic bottle.

Each bottle contains 2.5 ml, 5 ml, or 10 ml of the medicine.

Alphagan is available in packs of 1, 3, or 6 bottles.

Not all packs may be marketed.

Marketing authorisation holder and manufacturer

Marketing authorisation holder:

AbbVie Spain, S.L.U.

Avenida de Burgos 91

28050, Madrid

Spain

Manufacturer:

Allergan Pharmaceuticals Ireland,

Westport, Co. Mayo,

Ireland

This medicine is authorised in the Member States of the European Economic Area under the following names:

Austria

Alphagan 0,2% Augentropfen

Germany

Alphagan 0,2 % m/V (2 mg/ml) Augentropfen

Belgium, Finland, Greece, Iceland, Luxembourg, Norway, Portugal

Alphagan

Denmark, Ireland, Italy, Netherlands, Sweden, United Kingdom

Alphagan 0.2%

France

ALPHAGAN 0,2% (2mg/ml), collyre en solution

Spain

Alphagan 2 mg/ml eye drops, solution

This leaflet was approved in 09/2020

Detailed and up-to-date information on this medicine is available on the website of the Spanish Medicines and Healthcare Products Agency (AEMPS) http://www.aemps.gob.es

Online doctors for ALPHAGAN 2 mg/ml EYE DROPS SOLUTION

Discuss questions about ALPHAGAN 2 mg/ml EYE DROPS SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ALPHAGAN 2 mg/ml EYE DROPS SOLUTION?
ALPHAGAN 2 mg/ml EYE DROPS SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ALPHAGAN 2 mg/ml EYE DROPS SOLUTION?
The active ingredient in ALPHAGAN 2 mg/ml EYE DROPS SOLUTION is brimonidine. This information helps identify medicines with the same composition but different brand names.
How much does ALPHAGAN 2 mg/ml EYE DROPS SOLUTION cost in pharmacies?
The average pharmacy price for ALPHAGAN 2 mg/ml EYE DROPS SOLUTION is around 7.31 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ALPHAGAN 2 mg/ml EYE DROPS SOLUTION?
ALPHAGAN 2 mg/ml EYE DROPS SOLUTION is manufactured by Abbvie Spain, S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ALPHAGAN 2 mg/ml EYE DROPS SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ALPHAGAN 2 mg/ml EYE DROPS SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ALPHAGAN 2 mg/ml EYE DROPS SOLUTION?
Other medicines with the same active substance (brimonidine) include ABRADEL 2 mg/ml EYE DROPS SOLUTION, BRIMONIDINE VIATRIS 2 mg/ml EYE DROPS SOLUTION, BRIMONIDINE VIR 2 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media